1. Home
  2. BBDC vs PHVS Comparison

BBDC vs PHVS Comparison

Compare BBDC & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBDC
  • PHVS
  • Stock Information
  • Founded
  • BBDC 2006
  • PHVS 2015
  • Country
  • BBDC United States
  • PHVS Netherlands
  • Employees
  • BBDC N/A
  • PHVS N/A
  • Industry
  • BBDC Diversified Financial Services
  • PHVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BBDC Finance
  • PHVS Health Care
  • Exchange
  • BBDC Nasdaq
  • PHVS Nasdaq
  • Market Cap
  • BBDC 1.0B
  • PHVS 1.0B
  • IPO Year
  • BBDC 2007
  • PHVS 2021
  • Fundamental
  • Price
  • BBDC $9.70
  • PHVS $22.61
  • Analyst Decision
  • BBDC Hold
  • PHVS Buy
  • Analyst Count
  • BBDC 2
  • PHVS 6
  • Target Price
  • BBDC $10.00
  • PHVS $35.67
  • AVG Volume (30 Days)
  • BBDC 298.4K
  • PHVS 95.8K
  • Earning Date
  • BBDC 11-06-2024
  • PHVS 11-15-2024
  • Dividend Yield
  • BBDC 10.72%
  • PHVS N/A
  • EPS Growth
  • BBDC 21.55
  • PHVS N/A
  • EPS
  • BBDC 1.09
  • PHVS N/A
  • Revenue
  • BBDC $291,393,000.00
  • PHVS N/A
  • Revenue This Year
  • BBDC N/A
  • PHVS N/A
  • Revenue Next Year
  • BBDC N/A
  • PHVS N/A
  • P/E Ratio
  • BBDC $8.91
  • PHVS N/A
  • Revenue Growth
  • BBDC 5.26
  • PHVS N/A
  • 52 Week Low
  • BBDC $8.55
  • PHVS $15.00
  • 52 Week High
  • BBDC $10.24
  • PHVS $33.00
  • Technical
  • Relative Strength Index (RSI)
  • BBDC 48.23
  • PHVS 52.81
  • Support Level
  • BBDC $9.57
  • PHVS $22.86
  • Resistance Level
  • BBDC $9.88
  • PHVS $25.40
  • Average True Range (ATR)
  • BBDC 0.16
  • PHVS 1.49
  • MACD
  • BBDC -0.00
  • PHVS -0.12
  • Stochastic Oscillator
  • BBDC 59.82
  • PHVS 31.85

About BBDC Barings BDC Inc.

Barings BDC Inc operates as a closed-end, non-diversified investment company and has elected to be treated as a business development company. The company's investment objective is to generate current income by investing directly in privately held middle-market companies to help these companies fund acquisitions, growth, or refinancing. Barings employs fundamental credit analysis and targets investments in businesses with low levels of cyclicality and operating risk relative to other businesses in this market segment. The holding size of each position will generally be dependent upon a number of factors including total facility size, pricing and structure, and the number of other lenders in the facility.

About PHVS Pharvaris N.V.

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. The company's activities are considered to be one segment which comprises the discovery, development and commercialization of oral bradykinin-B2-receptor antagonists .

Share on Social Networks: